Following approval by CRG and GMMMG, and by the Greater Manchester ICS Clinical Effectiveness and Governance Committee, the revised GMMMG shared care protocol for apomorphine for adult patients is now available.
The updated document can be found on the shared care page, along with all other currently active SCPs.
Following the first meeting of the Greater Manchester ICS Clinical Effectiveness and Governance Committee on Thursday 22nd September, the GMMMG charter has been approved and published.
The charter is available on the website by clicking here.
Following approval by CRG and GMMMG, and the first meeting of the Greater Manchester ICS Clinical Effectiveness and Governance Committee on Thursday 22nd September, the following shared care protocols have been updated:
All of the currently active shared care protocols are available on the shared care page.
On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed at the August 2022 CRG meeting.
Actions in this consultation include:
All links to MHRA drug safety updates will be added to formulary as appropriate.
To take part in this consultation, visit the consultations page. The consultation period is open until 5pm on Wednesday 28th September 2022.
On behalf of the GMMMG Clinical Reference Group, two GMMMG shared care protocols have been drafted for:
We now seek comments on these drafts, which are available from the GMMMG consultations page. The consultation period is open until 5pm on Monday 12th September.
On behalf of the GMMMG Clinical Reference Group, we now seek comments on the actions proposed at the June 2022 CRG meeting.
Actions in this consultation include:
For information:
To take part in this consultation, visit the consultations page. The consultation period is open until 5pm on Thursday 28th July 2022